Latest AI and machine learning research in heart transplantation for healthcare professionals.
Despite the increasing recognition of pyroptosis, particularly that involving GSDME, its precise impact on tumor prognosis and the immune microenvironment remains elusive, necessitating a comprehensive investigation in the context of lung adenocarcinoma (LUAD). We aimed to construct a pyroptosis-related prognostic model and to elucidate the intricate dynamics of GSDME-mediated pyroptosis in shapin...
BACKGROUND: Metabolic reprogramming is a hallmark of cancer. However, the precise mechanisms by which specific metabolic pathways drive prostate cancer (PCa) progression and shape the tumor microenvironment remain poorly defined. METHODS: A machine learning-derived Metabolic Dysfunction Signature (MODS) was developed and validated as a prognostic model. Its clinical relevance was established throu...
Hepatocellular carcinoma remains a leading cause of cancer mortality worldwide, with peritumoral microenvironment interactions playing a critical role...
UNLABELLED: Multiplexed imaging of tissues is an approach that holds promise for improving early detection, diagnosis, and treatment of cancer. In thi...
Fibroblastic proliferation in various tumor microenvironments influences cancer survival through complex interactions with diverse immune responses. T...
Liver Hepatocellular Carcinoma (LIHC) is a high-mortality primary liver cancer. Its treatment and prognosis are highly dependent on disease stage and ...
Edge-cloud computing has emerged as an important paradigm for modern Internet of Things (IoT) workflow applications, enabling low latency and on-deman...
SUMOylation is a critical post-translational modification of proteins. However, the roles of SUMOylation-related genes in regulating the tumor immune ...
BACKGROUND: Immune checkpoint blockade (ICB) therapy has provided a promising treatment option for patients with triple-negative breast cancer (TNBC)....
PURPOSE: Despite Phosphoenolpyruvate carboxykinase 2 (PCK2) has attracted growing attention as a potential biomarker in cancer research, its role in m...
INTRODUCTION: Our objective is to delineate the evolution of lupus nephritis (LN) histological classifications and management, from their origins to t...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) exhibits profound molecular heterogeneity, and reliable biomarkers for predicting clinical outcome...
As large language models transform software development, they introduce significant ethical and safety risks, with research revealing a 78.67% probabi...
BACKGROUND: Sarcopenia and myosteatosis reflect muscle quantity and quality and are linked to adverse outcomes in chronic diseases. Their role in pred...
BACKGROUND: Tumor evolution is a spatiotemporal dynamic process orchestrated by the interplay of genetic mutations, epigenetic reprogramming, and bidi...
BACKGROUND: Mitochondria-associated endoplasmic reticulum membranes (MAM) play a critical regulatory role in cancer, yet their function in bladder can...
OBJECTIVES: Electronic Health Records (EHRs) contain a wealth of unstructured patient data that can be leveraged using Artificial Intelligence (AI). T...
Chimeric antigen receptor natural killer (CAR-NK) cell therapy is an emerging cancer treatment offering advantages over CAR-T therapy, including reduc...
Glioblastoma (GBM) is an aggressive brain tumor with highly variable patient outcomes due to pronounced molecular heterogeneity. Prognosis remains dis...
Ulcerative colitis (UC) represents a chronic, relapsing inflammatory condition primarily affecting the colonic and rectal mucosa, presenting substanti...